Serum Biomarkers for Early Detection of Gynecologic Cancers
AbstractOvarian, endometrial, and cervical cancers are three of the most common malignancies of the female reproductive organs. CA 125, historically the most reliable serum marker for ovarian cancer, is elevated in 50% of early-stage ovarian tumors. For endometrial cancers, there are no established serum markers. SCC, which is the best studied serum marker for squamous cell carcinomas, has been unreliable; SCC is elevated in cervical squamous cell carcinomas ranging from 28–85% of the time. Recent proteomics-based analyses show great promise for the discovery of new and more useful biomarkers. In this review, we will discuss the currently utilized serum tumor markers for gynecologic cancers and the novel biomarkers that are now under investigation.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Ueda, Y.; Enomoto, T.; Kimura, T.; Miyatake, T.; Yoshino, K.; Fujita, M.; Kimura, T. Serum Biomarkers for Early Detection of Gynecologic Cancers. Cancers 2010, 2, 1312-1327.
Ueda Y, Enomoto T, Kimura T, Miyatake T, Yoshino K, Fujita M, Kimura T. Serum Biomarkers for Early Detection of Gynecologic Cancers. Cancers. 2010; 2(2):1312-1327.Chicago/Turabian Style
Ueda, Yutaka; Enomoto, Takayuki; Kimura, Toshihiro; Miyatake, Takashi; Yoshino, Kiyoshi; Fujita, Masami; Kimura, Tadashi. 2010. "Serum Biomarkers for Early Detection of Gynecologic Cancers." Cancers 2, no. 2: 1312-1327.